Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.
2.

Epstein-Barr virus-encoded LMP1 promotes cisplatin-induced caspase activation through JNK and NF-kappaB signaling pathways.

Zhang X, Sanmun D, Hu L, Fadeel B, Ernberg I.

Biochem Biophys Res Commun. 2007 Aug 17;360(1):263-8. Epub 2007 Jun 18.

PMID:
17586463
3.
4.
5.

Silencing of LMP1 induces cell cycle arrest and enhances chemosensitivity through inhibition of AKT signaling pathway in EBV-positive nasopharyngeal carcinoma cells.

Mei YP, Zhou JM, Wang Y, Huang H, Deng R, Feng GK, Zeng YX, Zhu XF.

Cell Cycle. 2007 Jun 1;6(11):1379-85. Epub 2007 Jun 11.

PMID:
17507800
6.

Regulation of DNA Damage Signaling and Cell Death Responses by Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) and LMP2A in Nasopharyngeal Carcinoma Cells.

Wasil LR, Wei L, Chang C, Lan L, Shair KH.

J Virol. 2015 Aug;89(15):7612-24. doi: 10.1128/JVI.00958-15. Epub 2015 May 13.

8.
9.
10.

EBV-encoded LMP-1 sensitizes nasopharyngeal carcinoma cells to genotoxic drugs by down-regulating Cabin1 expression.

Chang PY, Wu ZZ, Sun NK, Chao CC.

J Cell Physiol. 2014 Mar;229(3):309-22. doi: 10.1002/jcp.24448.

PMID:
23939952
11.

Epstein-Barr virus latent membrane protein 1 (LMP1) upregulates Id1 expression in nasopharyngeal epithelial cells.

Li HM, Zhuang ZH, Wang Q, Pang JC, Wang XH, Wong HL, Feng HC, Jin DY, Ling MT, Wong YC, Eliopoulos AG, Young LS, Huang DP, Tsao SW.

Oncogene. 2004 May 27;23(25):4488-94.

PMID:
15064751
12.

Expression of immune-related molecules in primary EBV-positive Chinese nasopharyngeal carcinoma: associated with latent membrane protein 1 (LMP1) expression.

Li J, Zhang XS, Xie D, Deng HX, Gao YF, Chen QY, Huang WL, Masucci MG, Zeng YX.

Cancer Biol Ther. 2007 Dec;6(12):1997-2004. Epub 2007 Oct 13.

PMID:
18087217
13.

Transformation of Madin-Darby canine kidney (MDCK) epithelial cells by Epstein-Barr virus latent membrane protein 1 (LMP1) induces expression of Ets1 and invasive growth.

Kim KR, Yoshizaki T, Miyamori H, Hasegawa K, Horikawa T, Furukawa M, Harada S, Seiki M, Sato H.

Oncogene. 2000 Mar 30;19(14):1764-71.

14.
15.

Epstein-Barr Virus_Encoded LMP1 upregulates microRNA-21 to promote the resistance of nasopharyngeal carcinoma cells to cisplatin-induced Apoptosis by suppressing PDCD4 and Fas-L.

Yang GD, Huang TJ, Peng LX, Yang CF, Liu RY, Huang HB, Chu QQ, Yang HJ, Huang JL, Zhu ZY, Qian CN, Huang BJ.

PLoS One. 2013 Oct 23;8(10):e78355. doi: 10.1371/journal.pone.0078355. eCollection 2013.

16.

Role of Epstein-Barr virus encoded latent membrane protein 1 in the carcinogenesis of nasopharyngeal carcinoma.

Zheng H, Li LL, Hu DS, Deng XY, Cao Y.

Cell Mol Immunol. 2007 Jun;4(3):185-96. Review.

17.
18.

Antiviral agent cidofovir decreases Epstein-Barr virus (EBV) oncoproteins and enhances the radiosensitivity in EBV-related malignancies.

Abdulkarim B, Sabri S, Zelenika D, Deutsch E, Frascogna V, Klijanienko J, Vainchenker W, Joab I, Bourhis J.

Oncogene. 2003 Apr 17;22(15):2260-71.

PMID:
12700662
19.

Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma.

Faqing T, Zhi H, Liqun Y, Min T, Huanhua G, Xiyun D, Ya C.

Exp Oncol. 2005 Jun;27(2):96-101.

PMID:
15995625

Supplemental Content

Support Center